论文部分内容阅读
[目的]观察单硝酸异山梨酯与参麦注射液联合应用治疗冠心病心绞痛(胸痹气阴两虚型或伴心血瘀阻型)的临床疗效和安全性。[方法]对150例病例随机分成两组,对照组75例应用单硝酸异山梨酯等西药常规治疗,治疗组75例给予单硝酸异山梨酯等西药常规治疗的同时,配合参麦注射液治疗。15天后对胸痹症状、心电图、症状疗效进行观察比较。[结果]治疗组明显改善胸痹症状,总有效率为93.3%,心电图疗效总有效率为96%;对照组改善胸痹症状总有效率为84%,心电图疗效总有效率为80%,有显著性差异,无不良反应。
[Objective] To observe the clinical efficacy and safety of isosorbide mononitrate combined with Shenmai injection in the treatment of coronary heart disease angina pectoris (thoracolumbic qi and yin deficiency type or with blood stasis syndrome type). [Method] 150 cases were randomly divided into two groups, the control group, 75 cases of isosorbide mononitrate and other western medicine routine treatment, the treatment group of 75 cases given isosorbide mononitrate and other western medicine routine treatment, with shenmai injection treatment . After 15 days of chest arthralgia, electrocardiogram, the efficacy of symptoms were observed and compared. [Results] The treatment group significantly improved the symptoms of chest arthrosis, the total effective rate was 93.3%, the total effective rate of electrocardiogram was 96%; the control group improved the total effective rate of chest arthralgia was 84%, the total effective rate of electrocardiogram was 80% Significant differences, no adverse reactions.